<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-29T20:31:12Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/32307" metadataPrefix="oai_dc">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/32307</identifier><datestamp>2026-02-03T11:21:43Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37953</setSpec></header><metadata><oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Ulcerative colitis impairs the acylethanolamide-based anti-inflammatory system reversal by 5-aminosalicylic acid and glucocorticoids.</dc:title>
   <dc:creator>Suárez-Pérez, Juan</dc:creator>
   <dc:creator>Romero-Zerbo, Silvana Yanina</dc:creator>
   <dc:creator>Márquez, Lucia</dc:creator>
   <dc:creator>Rivera-González, Patricia</dc:creator>
   <dc:creator>Iglesias, Mar</dc:creator>
   <dc:creator>Bermúdez Silva, Francisco Javier</dc:creator>
   <dc:creator>Andreu, Montserrat</dc:creator>
   <dc:creator>Rodriguez-de-Fonseca, Fernando</dc:creator>
   <dc:subject>Colitis ulcerosa - Investigación</dc:subject>
   <dc:subject>Enfermedad inflamatoria intestinal</dc:subject>
   <dc:subject>PPARa</dc:subject>
   <dc:subject>Ulcerative colitis</dc:subject>
   <dc:subject>Chronic inflamation</dc:subject>
   <dc:subject>Endocannabinoid system</dc:subject>
   <dc:subject>Glucocorticoids</dc:subject>
   <dc:description>Studies in animal models and humans suggest anti-inflammatory roles on the N-acylethanolamide (NAE)-peroxisome proliferators activated receptor alpha (PPARα) system in inflammatory bowel diseases. However, the presence and function of NAE-PPARα signaling system in the ulcerative colitis (UC) of humans remain unknown as well as its response to active anti-inflammatory therapies such as 5-aminosalicylic acid (5-ASA) and glucocorticoids. Expression of PPARα receptor and PPARα ligands-biosynthetic (NAPE-PLD) and -degrading (FAAH and NAAA) enzymes were analyzed in untreated active and 5-ASA/glucocorticoids/immunomodulators-treated quiescent UC patients compared to healthy human colonic tissue by RT-PCR and immunohistochemical analyses. PPARα, NAAA, NAPE-PLD and FAAH showed differential distributions in the colonic epithelium, lamina propria, smooth muscle and enteric plexus. Gene expression analysis indicated a decrease of PPARα, PPARγ and NAAA, and an increase of FAAH and iNOS in the active colitis mucosa. Immunohistochemical expression in active colitis epithelium confirmed a PPARα decrease, but showed a sharp NAAA increase and a NAPE-PLD decrease, which were partially restored to control levels after treatment. We also characterized the immune cells of the UC mucosa infiltrate. We detected a decreased number of NAAA-positive and an increased number of FAAH-positive immune cells in active UC, which were partially restored to control levels after treatment. NAE-PPARα signaling system is impaired during active UC and 5-ASA/glucocorticoids treatment restored its normal expression. Since 5-ASA actions may work through PPARα and glucocorticoids through NAE-producing/degrading enzymes, the use of PPARα agonists or FAAH/NAAA blockers that increases endogenous PPARα ligands may yield similar therapeutics advantages.</dc:description>
   <dc:date>2024-07-25T10:21:13Z</dc:date>
   <dc:date>2024-07-25T10:21:13Z</dc:date>
   <dc:date>2012</dc:date>
   <dc:type>journal article</dc:type>
   <dc:type>VoR</dc:type>
   <dc:identifier>Suárez J, Romero-Zerbo Y, Márquez L, Rivera P, Iglesias M, Bermúdez-Silva FJ, et al. (2012) Ulcerative Colitis Impairs the Acylethanolamide-Based Anti-Inflammatory System Reversal by 5-Aminosalicylic Acid and Glucocorticoids. PLoS ONE 7(5): e37729. https://doi.org/10.1371/journal.pone.0037729</dc:identifier>
   <dc:identifier>https://hdl.handle.net/10630/32307</dc:identifier>
   <dc:identifier>10.1371/journal.pone.0037729</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:rights>Atribución 4.0 Internacional</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
   <dc:rights>open access</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>PLOS</dc:publisher>
</oai_dc:dc>
</metadata></record></GetRecord></OAI-PMH>